The Company continues to enroll people living with HIV (PLWH) in the multiple ascending dose (MAD ... KIMMTRAK is a novel bispecific protein comprised of a soluble T cell receptor fused to an anti-CD3 ...
HIV cannot be spread through casual contact like hugs, handshakes, and sharing items in a household with someone who has HIV. However, despite increased public awareness, there remains a lot of ...
or later stages of an HIV infection. Because your body’s immune system is trying to fight off the first infection from HIV, the response can cause a rash. If you already have HIV, you may have ...
HIV is a virus that damages cells in the immune system and disrupts the body's ability to fight off infections and diseases. If the immune system is severely damaged by HIV, the person can develop ...
Primary immune thrombocytopenia is an autoimmune disease in which autoreactive B cells play a crucial role in pathogenesis by producing autoantibodies primarily directed against platelet surface ...
A checkpoint receptor that often resides on the surface of immune system cells, the PD-1 molecule works as a type of "off" switch that keeps immune cells from attacking other cells. After its ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year. Gilead Sciences, GSK, ViiV Healthcare 1 to 3 years In June 2024, results from a ...
Cell-to-cell spread can enable viruses to evade the humoral immune response ... that must engage more than one receptor to enter the cell (for example, HIV-1 (Ref. 1); Table 1).
This therapy is the first to activate specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments.
The winter vomiting bug is highly infectious and fast to evolve, but can we learn anything from groups of people who are unusually immune to the virus? When it comes to surviving in the ...